A novel role for B cells in early protective immunity to an intracellular pathogen, Francisella tularensis strain LVS

被引:0
|
作者
Culkin, SJ [1 ]
RhinehartJones, T [1 ]
Elkins, KL [1 ]
机构
[1] US FDA, LAB MYCOBACTERIA, DIV BACTERIAL PROD, CTR BIOL EVALUAT & RES, ROCKVILLE, MD 20852 USA
来源
JOURNAL OF IMMUNOLOGY | 1997年 / 158卷 / 07期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Normal BALB/cByJ mice given a sublethal infection of Francisella tularensis strain LVS survived 10(6) LD(50)s Of lethal challenge given only 3 days later. Here, we determine the cell types responsible for this very strong early protective immunity. Early protection is observed in athymic nu/nu mice but not fully immunodeficient scid mice, implicating a lymphocyte in this response. Using scid mice that are reconstituted with various purified cell subpopulations, as well as mice with genetically targeted disruptions in lymphocyte subpopulations (knockout mice), we demonstrate that strong early protection is highly dependent on B cells. This protective mechanism, which limits bacterial growth in the organs of the reticuloendothelial system very quickly after infection, requires IFN-gamma but is unlikely to involve specific Ab.
引用
收藏
页码:3277 / 3284
页数:8
相关论文
共 50 条
  • [1] The role of B cells in immunity to Francisella tularensis LVS
    Fernandez, E
    Elkins, K
    [J]. FASEB JOURNAL, 2004, 18 (05): : A805 - A805
  • [2] Interaction of B cells with intracellular pathogen Francisella tularensis
    Krocova, Zuzana
    Hartlova, Anetta
    Souckova, Dagmar
    Zivna, Lucie
    Kroca, Michal
    Rudolf, Emil
    Macela, Ales
    Stulik, Jiri
    [J]. MICROBIAL PATHOGENESIS, 2008, 45 (02) : 79 - 85
  • [3] Loss of either CD4(+) or CD8(+) T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS
    Yee, D
    RhinehartJones, TR
    Elkins, KL
    [J]. JOURNAL OF IMMUNOLOGY, 1996, 157 (11): : 5042 - 5048
  • [4] Purified lipopolysaccharide from Francisella tularensis live vaccine strain (LVS) induces protective immunity against LVS infection that requires B cells and gamma interferon
    Dreisbach, VC
    Cowley, S
    Elkins, KL
    [J]. INFECTION AND IMMUNITY, 2000, 68 (04) : 1988 - 1996
  • [5] Deficiency in CCR2 increases susceptibility of mice to infection with an intracellular pathogen, Francisella tularensis LVS, but does not impair development of protective immunity
    Kurtz, Sherry L.
    De Pascalis, Roberto
    Meierovics, Anda, I
    Elkins, Karen L.
    [J]. PLOS ONE, 2021, 16 (03):
  • [6] Early activation of NK cells after lung infection with the intracellular bacterium, Francisella tularensis LVS
    López, MC
    Duckett, NS
    Baron, SD
    Metzger, DW
    [J]. CELLULAR IMMUNOLOGY, 2004, 232 (1-2) : 75 - 85
  • [7] Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain
    Elkins, KL
    Bosio, CM
    Rhinehart-Jones, TR
    [J]. INFECTION AND IMMUNITY, 1999, 67 (11) : 6002 - 6007
  • [8] Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis
    Kirimanjeswara, Girish S.
    Olmos, Sofia
    Bakshi, Chandra S.
    Metzger, Dennis W.
    [J]. IMMUNOLOGICAL REVIEWS, 2008, 225 : 244 - 255
  • [9] The intracellular pathogen Francisella tularensis escapes from adaptive immunity by metabolic adaptation
    Shibata, Kensuke
    Shimizu, Takashi
    Nakahara, Mashio
    Ito, Emi
    Legoux, Francois
    Fujii, Shotaro
    Yamada, Yuka
    Furutani-Seiki, Makoto
    Lantz, Olivier
    Yamasaki, Sho
    Watarai, Masahisa
    Shirai, Mutsunori
    [J]. LIFE SCIENCE ALLIANCE, 2022, 5 (10)
  • [10] Immunization with heat-killed Francisella tularensis LVS elicits protective antibody-mediated immunity
    Lavine, Christy L.
    Clinton, Shawn R.
    Angelova-Fischer, Irena
    Marion, Tony N.
    Bina, Xiaowen R.
    Bina, James E.
    Whitt, Michael A.
    Miller, Mark A.
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2007, 37 (11) : 3007 - 3020